BDBM536466 (S)-5-(1-(2-((3-chloro- 6-(4-(cyclopropyl- methyl)-2-methyl- piperazin-1-yl)-2- fluoropyridin-4-yl) amino)-2-oxoethyl)- 4-oxo-1,4,6,7,8,9- hexahydropyrido [1,2-a]pyrrolo[2,3-d] pyrimidin-3-yl)-3,4- difluoro-2-hydroxy- benzamide::US11242351, Compound I-45

SMILES C[C@H]1CN(CC2CC2)CCN1c1cc(NC(=O)Cn2cc(-c3cc(C(N)=O)c(O)c(F)c3F)c3c2nc2CCCCn2c3=O)c(Cl)c(F)n1

InChI Key InChIKey=CLKGGMHVXWECBR-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536466   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536466((S)-5-(1-(2-((3-chloro- 6-(4-(cyclopropyl- methyl)...)
Affinity DataKd:  31.8nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In DepthDetails
US Patent